# EPOPROSTENOL SODIUM
> **ANDA210473** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2021-01-15
## Drug
- **FDA Application Number:** ANDA210473
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPOPROSTENOL SODIUM
- **Generic name:** EPOPROSTENOL
- **Active ingredients:** EPOPROSTENOL SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARM
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2021-01-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210473)
---
*MORVS · CC0 1.0*